Systemic infections and inflammation affect chronic neurodegeneration
The DOI matches its Crossref record; 91 of the 93 references it cites were found in a registry or an index.
Abstract
It is well known that systemic infections cause flare-ups of disease in individuals with asthma and rheumatoid arthritis, and that relapses in multiple sclerosis can often be associated with upper respiratory-tract infections. Here we review evidence to support our hypothesis that in chronic neurodegenerative diseases such as Alzheimer's disease, with an ongoing innate immune response in the brain, systemic infections and inflammation can cause acute exacerbations of symptoms and drive the progression of neurodegeneration.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“chronic systemic inflammation, mostly in the form of infections, has long been associated with behavioral alterations and cognitive dysfunction (50, 51).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [51]
In the citing paper
“gene expression by morphologically identical microglia can differ drastically contingent on context (Perry et al., 2007).”
From Differential roles of microglia and monocytes in the inflamed central nervous system (2014) · cites this paper as Perry et al., 2007
In the citing paper
“Both of these phenomena can be explained by the concept of phenotypic heterogeneity of microglial cell populations100.”
From From inflammation to sickness and depression: when the immune system subjugates the brain (2008) · cites this paper as [100]
In the citing paper
“For example, chronic neurodegenerative diseases are associated with increasing numbers of microglia100.”
From From inflammation to sickness and depression: when the immune system subjugates the brain (2008) · cites this paper as [100]
In the citing paper
“Furthermore, with the deposition of Aβ, the phenotype of microglial cells becomes more neurotoxic118,146–148: they express several inflammatory cytokines, including IL-1β, IL-6, tumour necrosis factor (TNF) and CCL3 (also known as MIP1α)146.”
From Microglial signatures and their role in health and disease (2018) · cites this paper as [147]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
Hu, R. J. (2003) · Encyclopedia of the Neurological Sciences · doi:10.1016/b0-12-226870-9/01070-4 · Cited by 9,117
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189 · cited 1×
“It is widely recognized that cells of the macrophage lineage exist in many states of activation, including pro-inflammatory, alternatively activated or even anti-inflammatory, following the ingestion of apoptotic cell”
BackgroundResting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827 · cited 1×
“Although the microglia are phenotypically downregulated, recent imaging studies in vivo show that these cells, even in their so-called resting state, are highly active, with their fine processes continually surveying their local microenvironmen”
BackgroundInflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396 · cited 1×
“Microglia are exquisitely sensitive to almost any disturbance of brain homeostasi”
BackgroundTracey, K. J. (2002) · Nature · doi:10.1038/nature01321 · Cited by 3,728 · cited 1×
“First, inflammatory events in the thoracic abdominal cavity are signalled to the brain through vagal-nerve sensory afferents, and in turn the vagal efferent outflow might modify these inflammatory events through acetylcholine secretio”
BackgroundImmunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Biological basis of the behavior of sick animals
Hart, B. L. (1988) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(88)80004-6 · Cited by 2,223
Diabetes mellitus and the risk of dementia: The Rotterdam Study
Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175
Bard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., et al. (2000) · Nature Medicine · doi:10.1038/78682 · Cited by 2,012
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265 · cited 1×
“and possible recruitment of monocytes from the bloo”
BackgroundDown-Regulation of the Macrophage Lineage Through Interaction with OX2 (CD200)
Hoek, R. M., Ruuls, S. R., Murphy, C. A., Wright, G. J., Goddard, R., Zurawski, S. M., Blom, B., Homola, M. E., Streit, W. J., Brown, M. H., et al. (2000) · Science · doi:10.1126/science.290.5497.1768 · Cited by 1,022
Stout, R. D., Jiang, C., Matta, B., Tietzel, I., Watkins, S. K., & Suttles, J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.342 · Cited by 968
Ibuprofen Suppresses Plaque Pathology and Inflammation in a Mouse Model for Alzheimer's Disease
Lim, G. P., Yang, F., Chu, T., Chen, P., Beech, W., Teter, B., Tran, T., Ubeda, O., Ashe, K. H., Frautschy, S. A., et al. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-15-05709.2000 · Cited by 884
Raivich, G., Bohatschek, M., Kloss, C. U. A., Werner, A., Jones, L. L., & Kreutzberg, G. W. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00007-7 · Cited by 844 · cited 1×
“It has been proposed that microglia show incremental linear stages of activation and that their functional phenotype might be inferred from their morpholog”
BackgroundMcGeer, P. L., Itagaki, S., Tago, H., & McGeer, E. G. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90696-3 · Cited by 836 · cited 1×
“An atypical inflammatory response dominated by cells of the macrophage lineage occurs, with both activation of the resident microglial cell”
BackgroundGodbout, J. P., Chen, J., Abraham, J., Richwine, A. F., Berg, B. M., Kelley, K. W., & Johnson, R. W. (2005) · The FASEB Journal · doi:10.1096/fj.05-3776fje · Cited by 813
Cunningham, C., Wilcockson, D. C., Campion, S., Lunnon, K., & Perry, V. H. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2614-05.2005 · Cited by 768 · cited 1×
“We have recently shown that a systemic inflammatory challenge in an animal with a chronic neurodegenerative disease leads to exaggerated brain inflammation, exaggerated sickness behaviour and a significant increase in acute neurodegeneratio”
BackgroundSelf-citationMacrophages and microglia in the nervous system
Perry, V. H., & Gordon, S. (1988) · Trends in Neurosciences · doi:10.1016/0166-2236(88)90110-5 · Cited by 745 · cited 1×
“The microglia are characterized in the normal brain by their highly branched morphology and downregulated phenotyp”
BackgroundSelf-citationCytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity
Dantzer, R. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.040 · Cited by 743 · cited 1×
“Three major routes of communication are known, all of which lead to the synthesis of cytokines and inflammatory mediators in the brain parenchyma, which are typically associated with tissue injur”
BackgroundCombs, C. K., Karlo, J. C., Kao, S.-C., & Landreth, G. E. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-04-01179.2001 · Cited by 721
Fleminger, S. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.7.857 · Cited by 719
Kitazawa, M., Oddo, S., Yamasaki, T. R., Green, K. N., & LaFerla, F. M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2868-05.2005 · Cited by 697
Delirium Superimposed on Dementia: A Systematic Review
Fick, D. M., Agostini, J. V., & Inouye, S. K. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50468.x · Cited by 636 · cited 1×
“Patients with dementia are particularly susceptible to developing delirium, indicating similar aetiological pathway”
BackgroundPredictors of cognitive decline and mortality of aged people over a 10‐year period
Tilvis, R. S., Kahonen-Vare, M. H., Jolkkonen, J., Valvanne, J., Pitkala, K. H., & Strandberg, T. E. (2004) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/59.3.m268 · Cited by 578
Bogdan, C., Paik, J., Vodovotz, Y., & Nathan, C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50091-0 · Cited by 512
Etminan, M., Gill, S., & Samii, A. (2003) · BMJ · doi:10.1136/bmj.327.7407.128 · Cited by 511
Role of microglia and host prion protein in neurotoxicity of a prion protein fragment
Brown, D. R., Schmidt, B., & Kretzschmar, H. A. (1996) · Nature · doi:10.1038/380345a0 · Cited by 502
A Cell Surface Receptor Complex for Fibrillar β-Amyloid Mediates Microglial Activation
Bamberger, M. E., Harris, M. E., McDonald, D. R., Husemann, J., & Landreth, G. E. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-07-02665.2003 · Cited by 501
Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease
Chen, H., Jacobs, E., Schwarzschild, M. A., McCullough, M. L., Calle, E. E., Thun, M. J., & Ascherio, A. (2005) · Annals of Neurology · doi:10.1002/ana.20682 · Cited by 472
McCusker, J., Cole, M. G., Dendukuri, N., Belzile, É., & Primeau, F. (2001) · Europe PMC (PubMed Central) · Cited by 454
Microglial Phagocytosis of Fibrillar β-Amyloid through a β1Integrin-Dependent Mechanism
Koenigsknecht, J., & Landreth, G. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2557-04.2004 · Cited by 446
Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice
Wyss-Coray, T., Yan, F., Lin, A. H.-T., Lambris, J. D., Alexander, J. J., Quigg, R. J., & Masliah, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162350199 · Cited by 446
The impact of systemic infection on the progression of neurodegenerative disease
Perry, V. H., Newman, T. A., & Cunningham, C. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1032 · Cited by 428 · cited 1×
“We have proposed that the activated microglia observed in the brains of mice with prion disease, although exhibiting an anti-inflammatory phenotype, are primed by the ongoing pathology, and that their phenotype can be switched by an inflammatory challeng”
BackgroundSelf-citationChakravarty, S., & Herkenham, M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4268-04.2005 · Cited by 396
Altered antigen expression of microglia in the aged rodent CNS
Perry, V. H., Matyszak, M. K., & Fearn, S. (1993) · Glia · doi:10.1002/glia.440070111 · Cited by 368 · cited 1×
“It is known that neurodegeneration occurs during normal ageing, and this is associated with microglial activatio”
BackgroundSelf-citationSriram, K., Matheson, J. M., Benkovic, S. A., Miller, D. B., Luster, M. I., & O'Callaghan, J. P. (2002) · The FASEB Journal · doi:10.1096/fj.02-0216fje · Cited by 362 · cited 1×
“In models of Parkinson's disease, the transcription of pro-inflammatory cytokines is modestly increase”
BackgroundSchmid, C. D., Sautkulis, L. N., Danielson, P. E., Cooper, J., Hasel, K. W., Hilbush, B. S., Sutcliffe, J. G., & Carson, M. J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01243.x · Cited by 351
Pathway across the blood–brain barrier
Ek, M., Engblom, D., Saha, S., Blomqvist, A., Jakobsson, P.-J., & Ericsson-Dahlstrand, A. (2001) · Nature · doi:10.1038/35068632 · Cited by 348 · cited 1×
“, might interact directly with the brain endothelium, communicating directly across the blood–brain barrier and to perivascular macrophages, possibly through the induction of lipid mediators, in particular, prostaglandin E 2 (PGE 2 ) (Ref”
BackgroundA prospective longitudinal study of apathy in Alzheimer's disease
Starkstein, S. E. (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.069575 · Cited by 339 · cited 1×
“80 ); it has also been shown to be associated with a markedly increased rate of cognitive decline in these subject”
BackgroundMcDonald, P. P., Fadok, V. A., Bratton, D. L., & Henson, P. M. (1999) · PubMed · Cited by 332
Peripheral infection and aging interact to impair hippocampal memory consolidation
Barrientos, R. M., Higgins, E. A., Biedenkapp, J. C., Sprunger, D. B., Wright-Hardesty, K. J., Watkins, L. R., Rudy, J. W., & Maier, S. F. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.03.010 · Cited by 331 · cited 1×
“, and more recent studies have shown that hippocampal-dependent learning deficits are induced by peripheral LPS in aged rats but not in younger control”
BackgroundSystemic infection, interleukin 1beta, and cognitive decline in Alzheimer's disease
Holmes, C. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.6.788 · Cited by 329
Self-citationModulation of cytokine production by transforming growth factor-beta.
Chantry, D., Turner, M., Abney, E., & Feldmann, M. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.12.4295 · Cited by 323
Clark, C. M. (1999) · Archives of Neurology · doi:10.1001/archneur.56.7.857 · Cited by 298 · cited 1×
“3b ), and this is evident from a large number of studies that have examined cognitive performance over short and long periods of tim”
BackgroundPattern Recognition by TREM-2: Binding of Anionic Ligands
Daws, M. R., Sullam, P. M., Niemi, E. C., Chen, T. T., Tchao, N. K., & Seaman, W. E. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.594 · Cited by 291 · cited 1×
“11 ) and microglial expression of TREM2 (triggering receptor expressed by myeloid cells 2) (Ref”
BackgroundMcDonald, P. P., Fadok, V. A., Bratton, D., & Henson, P. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.11.6164 · Cited by 290
Simone, R. D., Ajmone‐Cat, M. A., Carnevale, D., & Minghetti, L. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-4 · Cited by 275
Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease
Cunningham, C., Deacon, R., Wells, H., Boche, D., Waters, S., Diniz, C. P., Scott, H., Rawlins, J. N. P., & Perry, V. H. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02662.x · Cited by 266
Self-citationNguyen, M. D., D'Aigle, T., Gowing, G., Julien, J.-P., & Rivest, S. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4786-03.2004 · Cited by 248 · cited 1×
“Repeated systemic challenges with high doses of LPS in the SOD1 G37R model of amyotrophic lateral sclerosis also led to the exacerbation of symptoms, the increased loss of motor neurons and a shortened survival tim”
BackgroundGriffin, W. S. T., & Mrak, R. E. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.2.233 · Cited by 248 · cited 1×
“Much has been written about the role of pro-inflammatory cytokines, such as interleukin-1β (IL-1β), in Alzheimer's diseas”
BackgroundA Cross-Sectional Study of Neuropsychiatric Symptoms in 435 Patients With Alzheimer's Disease
Craig, D., Mirakhur, A., Hart, D. J., McIlroy, S. P., & Passmore, A. P. (2005) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200506000-00004 · Cited by 239
Depino, A. M., Earl, C., Kaczmarczyk, E., Ferrari, C., Besedovsky, H., Del Rey, A., Pitossi, F. J., & Oertel, W. H. (2003) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2003.03014.x · Cited by 236 · cited 1×
“In models of Parkinson's disease, the transcription of pro-inflammatory cytokines is modestly increase”
BackgroundPeripheral infection evokes exaggerated sickness behaviour in pre-clinical murine prion disease
Combrinck, M. I., Perry, V. H., & Cunningham, C. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00030-1 · Cited by 231 · cited 1×
“We have recently shown that a systemic inflammatory challenge in an animal with a chronic neurodegenerative disease leads to exaggerated brain inflammation, exaggerated sickness behaviour and a significant increase in acute neurodegeneratio”
BackgroundSelf-citationIbuprofen effects on Alzheimer pathology and open field activity in APPsw transgenic mice
Lim, G. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00299-8 · Cited by 227
Intrahippocampal LPS injections reduce Aβ load in APP+PS1 transgenic mice
DiCarlo, G. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00292-5 · Cited by 223
Hensley, K. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00087-1 · Cited by 220 · cited 1×
“; the protein products of these genes are not generally examined, but where they have been assessed they are elevated less than twofol”
BackgroundThe microglial phagocytic role with specific plaque types in the Alzheimer disease brain
D’Andrea, M. R., Cole, G. M., & Ard, M. D. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.12.026 · Cited by 215 · cited 1×
“; they also surround dense-core (senile) amyloid-β 1–40/42 plaque”
BackgroundYe, S.-M., & Johnson, R. W. (2001) · Neuroimmunomodulation · doi:10.1159/000049025 · Cited by 203
Wilcock, D. M., Munireddy, S. K., Rosenthal, A., Ugen, K. E., Gordon, M. N., & Morgan, D. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.09.015 · Cited by 202
Hensley, K., Floyd, R. A., Gordon, B., Mou, S., Pye, Q. N., Stewart, C., West, M., & Williamson, K. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00968.x · Cited by 198 · cited 1×
“There are several reports of elevated pro-inflammatory cytokine expression, but the increases are only twofold to fourfol”
BackgroundAssociation between Dementia and Infectious Disease: Evidence from a Case-Control Study
Dunn, N., Mullee, M., Perry, V. H., & Holmes, C. (2005) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000165511.52746.1f · Cited by 197 · cited 1×
“In a retrospective general-practitioner database study, the presence of two or more infections over a 4-year follow-up period increased the odds of developing Alzheimer's disease by around twofol”
BackgroundSelf-citationRobert, P. H., Berr, C., Volteau, M., Bertogliati, C., Benoit, M., Sarazin, M., Legrain, S., & Dubois, B. (2006) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2006.02.003 · Cited by 185
Laflamme, N., & Rivest, S. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730309.x · Cited by 182
Sly, L. M., Krzesicki, R. F., Brashler, J. R., Buhl, A. E., McKinley, D. D., Carter, D. B., & Chin, J. E. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00730-4 · Cited by 174
Interleukin-6 in the aging brain
Godbout, J. P., & Johnson, R. W. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.10.031 · Cited by 173 · cited 1×
“and modest increases in pro-inflammatory cytokine expressio”
Time-dependent reduction in Aβ levels after intracranial LPS administration in APP transgenic mice
Herber, D. L., Roth, L. M., Wilson, D. H., Wilson, N., Mason, J. E., Morgan, D., & Gordon, M. N. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.07.007 · Cited by 170
Mott, R. T., Ait‐Ghezala, G., Town, T., Mori, T., Vendrame, M., Zeng, J., Ehrhart, J., Mullan, M., & Tan, J. (2004) · Glia · doi:10.1002/glia.20009 · Cited by 170
Hope, T., Keene, J., Fairburn, C. G., Jacoby, R., & McShane, R. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.174.1.39 · Cited by 154 · cited 1×
“Few prospective studies have followed the natural course of these symptoms in Alzheimer's disease but, in keeping with the hypothesis that they are a consequence of systemic inflammatory events, they are largely non-persistent and periodic in nature, with a highly variable period of duratio”
BackgroundYip, A. G., Brayne, C., & Matthews, F. E. (2006) · Age and Ageing · doi:10.1093/ageing/afj030 · Cited by 141
Nguyen, M. D., Julien, J., & Rivest, S. (2001) · Annals of Neurology · doi:10.1002/ana.1256 · Cited by 129
Mabbott, N. A., Williams, A., Farquhar, C. F., Pasparakis, M., Kollias, G., & Bruce, M. E. (2000) · Journal of Virology · doi:10.1128/jvi.74.7.3338-3344.2000 · Cited by 126
Kyrkanides, S., O’Banion, M. K., Whiteley, P. E., Daeschner, J., & Olschowka, J. A. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00404-0 · Cited by 117
Rahkonen, T. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.69.4.519 · Cited by 117 · cited 1×
“Delirium has been shown in several studies to be associated with a significantly increased risk of developing dementi”
BackgroundDepression and the Risk of Alzheimer Disease
Andersen, K., Lolk, A., Kragh-S??rensen, P., Petersen, N. E., & Green, A. (2005) · Epidemiology · doi:10.1097/01.ede.0000152116.32580.24 · Cited by 113
Role of Interleukin-1 in Prion Disease-Associated Astrocyte Activation
Schultz, J., Schwarz, A., Neidhold, S., Burwinkel, M., Riemer, C., Simon, D., Köpf, M., Otto, M., & Baier, M. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63331-7 · Cited by 109 · cited 1×
“Similarly, knockouts of cytokine genes or their receptors have either minor or no effects on disease progressio”
BackgroundInflammation and cerebral amyloidosis are disconnected in an animal model of Alzheimer's disease
Quinn, J. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(03)00037-7 · Cited by 102
Role of TNF-α Receptors in Mice Intoxicated with the Parkinsonian Toxin MPTP
Rousselet, E., Callebert, J., Parain, K., Joubert, C., Hunot, S., Hartmann, A., Jacque, C., Pérez-Díaz, F., Cohen‐Salmon, C., Launay, J., et al. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7960 · Cited by 94 · cited 1×
“, and both genetic manipulation of cytokines and pharmacological disruption of some aspects of inflammation have shown inconsistent effect”
BackgroundMattson, M. P., Lee, J., & Chan, S. L. (2002) · NeuroMolecular Medicine · doi:10.1385/nmm:2:1:29 · Cited by 90
TGFβ1 regulates the inflammatory response during chronic neurodegeneration
Boche, D., Cunningham, C., Docagne, F., Scott, H., & Perry, V. H. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.01.004 · Cited by 89
Self-citationHolmes, C. (2003) · Age and Ageing · doi:10.1093/ageing/32.2.200 · Cited by 82 · cited 1×
“3b ), and this is evident from a large number of studies that have examined cognitive performance over short and long periods of tim”
BackgroundSelf-citationCunningham, C., Boche, D., & Perry, V. H. (2002) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2002.00383.x · Cited by 81
Self-citationAccelerated Prion Disease in the Absence of Interleukin-10
Thackray, A. M., McKenzie, A. N., Klein, M. A., Lauder, A., & Bujdoso, R. (2004) · Journal of Virology · doi:10.1128/jvi.78.24.13697-13707.2004 · Cited by 77
Ajmone‐Cat, M. A., Nicolini, A., & Minghetti, L. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02087.x · Cited by 75
Felton, L. M., Cunningham, C., Rankine, E. L., Waters, S., Boche, D., & Perry, V. H. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.03.008 · Cited by 70 · cited 1×
“Similarly, knockouts of cytokine genes or their receptors have either minor or no effects on disease progressio”
BackgroundSelf-citationBlond, D., Campbell, S. J., Butchart, A. G., Perry, V. H., & Anthony, D. C. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03473-x · Cited by 64
Self-citationCunningham, C., Wilcockson, D. C., Boche, D., & Perry, V. H. (2005) · Journal of Virology · doi:10.1128/jvi.79.8.5174-5184.2005 · Cited by 53
Self-citationTumor necrosis factor-alpha receptor ablation in a chronic MPTP mouse model of Parkinson's disease
Leng, A., Mura, A., Feldon, J., & Ferger, B. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.10.077 · Cited by 46 · cited 1×
“, and both genetic manipulation of cytokines and pharmacological disruption of some aspects of inflammation have shown inconsistent effect”
BackgroundBrown, A. R., Webb, J., Rebus, S., Walker, R., Williams, A., & Fazakerley, J. K. (2003) · Journal of General Virology · doi:10.1099/vir.0.19137-0 · Cited by 43
Schook, L. B., Albrecht, H., Gallay, P. A., & Jongeneel, C. V. (1994) · Journal of Leukocyte Biology · doi:10.1002/jlb.56.4.514 · Cited by 20
Inflammatory Proteins in Plasma and the Risk of Dementia: The Rotterdam Study
Engelhart, M. J., Geerlings, M. I., Meijer, J., Kiliaan, A., Ruitenberg, A., van Swieten, J. C., Stijnen, T., Hofman, A., Witteman, J. C. M., & Breteler, M. M. B. (2004) · Archives of Neurology · doi:10.1001/archneur.61.5.668 · Cited by 10 · cited 1×
“Inflammatory proteins in the plasma, notably C-reactive protein and IL-6, were found to be increased 5 years before the clinical onset of dementia in several studies, compared with age-matched individuals who did not go on to develop dementi”
Result
Cited by
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Mechanisms underlying inflammation in neurodegeneration
Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580
“Activation of the systemic innate immune system by infection may be involved in the early stages of AD pathogenesis (Perry et al., 2007).”
Kettenmann, H., Hanisch, U.-K., Noda, M., & Verkhratsky, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00011.2010 · Cited by 3,547
The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication
Silva, Y. P., Bernardi, A., & Frozza, R. L. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00025 · Cited by 3,043
“However, chronic systemic inflammation, mostly in the form of infections, has long been associated with behavioral alterations and cognitive dysfunction (50, 51).”
BackgroundSlavich, G. M., & Irwin, M. R. (2014) · Psychological Bulletin · doi:10.1037/a0035302 · Cited by 2,206
Metadata
- Authors
- Perry, V. H., Cunningham, C., & Holmes, C.
- Affiliations
- University of Southampton (GB)
- Corresponding author
- Perry, V. Hugh
- Venue
- Nature Reviews Immunology
- Published
- 2007-01-15
- Volume
- 7
- Issue
- 2
- Pages
- 161-167
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W1970606114
- Cited by
- 1,027
- References
- 93
- Citations by year
- 2026: 30 · 2025: 40 · 2024: 61 · 2023: 34 · 2022: 52 · 2021: 69 · 2020: 73 · 2019: 50 · 2018: 56 · 2017: 44 · 2016: 54 · 2015: 63 · 2014: 66 · 2013: 58 · 2012: 62
- FWCI
- 4.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- systemic infection, inflammation, chronic neurodegeneration, neuroinflammation, Alzheimer's disease, innate immune response, disease exacerbation, multiple sclerosis relapse, upper respiratory tract infection
- MeSH terms
- Aging, Animals, Brain, Communicable Diseases, Humans, Inflammation, Microglia, Neurodegenerative Diseases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.